Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K P Klugman

Showing results (1-10 of 166) with videos related to

Pageof 17
Sort By:
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|January 1, 1994
Centres of excellence for academic medicine in South AfricaK P Klugman
The Lancet. Infectious Diseases|March 2, 2002
Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistanceK P Klugman
Drugs|August 14, 2016
Trovafloxacin : A Viewpoint by Keith P. KlugmanK P Klugman
Emerging Infectious Diseases|December 29, 1998
Emerging infectious diseases--South AfricaK P Klugman
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 15, 2000
Levofloxacin-resistant pneumococcusK P Klugman
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 1, 1994
Activity of teicoplanin and vancomycin against penicillin-resistant pneumococciK P Klugman
The Journal of Antimicrobial Chemotherapy|August 1, 1994
Management of antibiotic-resistant pneumococcal infectionsK P Klugman
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|February 6, 2008
Risk factors for antibiotic resistance in Streptococcus pneumoniaeK P Klugman
The European Respiratory Journal. Supplement|August 10, 2002
Bacteriological evidence of antibiotic failure in pneumococcal lower respiratory tract infectionsK P Klugman
The Journal of Antimicrobial Chemotherapy|July 1, 1996
The clinical relevance of in-vitro resistance to penicillin, ampicillin, amoxycillin and alternative agents, for the treatment of community-acquired pneumonia caused by Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalisK P Klugman
Pageof 17

Showing results (1-10 of 166) with videos related to

Sort By:
Pageof 17
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|January 1, 1994
Centres of excellence for academic medicine in South AfricaK P Klugman
The Lancet. Infectious Diseases|March 2, 2002
Efficacy of pneumococcal conjugate vaccines and their effect on carriage and antimicrobial resistanceK P Klugman
Drugs|August 14, 2016
Trovafloxacin : A Viewpoint by Keith P. KlugmanK P Klugman
Emerging Infectious Diseases|December 29, 1998
Emerging infectious diseases--South AfricaK P Klugman
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 15, 2000
Levofloxacin-resistant pneumococcusK P Klugman
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 1, 1994
Activity of teicoplanin and vancomycin against penicillin-resistant pneumococciK P Klugman
The Journal of Antimicrobial Chemotherapy|August 1, 1994
Management of antibiotic-resistant pneumococcal infectionsK P Klugman
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|February 6, 2008
Risk factors for antibiotic resistance in Streptococcus pneumoniaeK P Klugman
The European Respiratory Journal. Supplement|August 10, 2002
Bacteriological evidence of antibiotic failure in pneumococcal lower respiratory tract infectionsK P Klugman
The Journal of Antimicrobial Chemotherapy|July 1, 1996
The clinical relevance of in-vitro resistance to penicillin, ampicillin, amoxycillin and alternative agents, for the treatment of community-acquired pneumonia caused by Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalisK P Klugman
Pageof 17